Mallia Therapeutics, a biopharmaceutical company focusing on hair loss treatments, has formed a strategic collaboration with Northway Biotech (NBT), a biologics Contract Development and Manufacturing Organization (CDMO), to scale up production of its soluble CD83 protein (sCD83). The partnership aims
Recipharm, a global contract development and manufacturing organisation (CDMO), has announced that its new modular sterile filling system is now fully operational at its Wasserburg, Germany facility. The system is designed to support process development, pilot-scale, and clinical supply manufacturing,
Viralgen and the CTNNB1 Foundation have announced a collaboration to develop an investigational gene therapy for CTNNB1 Syndrome, a rare neurodevelopmental disorder that affects motor and cognitive function. The therapy, produced using Viralgen’s AAV manufacturing platform, is expected to advance
Avid Bioservices has officially been acquired by GHO Capital Partners and Ampersand Capital Partners. The acquisition supports Avid’s next phase of growth, with a focus on service expansion, talent investment, and broader geographic reach. Avid, a biologics contract development and
EVA Pharma, an Egyptian pharmaceutical company, has partnered with France’s DNA Script and Belgium’s Quantoom Biosciences to establish Africa’s first end-to-end mRNA production platform. The partnership was formalised through a Memorandum of Understanding (MoU) signed during the 2nd Vaccine and
CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and API manufacturing company, has announced a leadership transition. CEO Pascal Villemagne will step down on 31 March 2025, after 13 years with the company, including three as CEO. The company has appointed
TriLink BioTechnologies, a subsidiary of Maravai LifeSciences, has entered into a non-exclusive License and Supply Agreement with Aldevron, a global CDMO specialising in the production of plasmid DNA, RNA, and proteins. This partnership aims to expand access to TriLink’s CleanCap
Katahdin Industries has announced the sale of Precision Coating to Integer Holdings Corporation, with the transaction closing on January 7, 2025. Precision Coating specialises in surface functionality solutions for Medtech customers, offering proprietary coatings and contract manufacturing services for medical
Jabil Inc. has completed the acquisition of Pharmaceutics International, Inc. (Pii), a CDMO specialising in aseptic filling, lyophilization, and oral solid dose manufacturing. The transaction, finalised on February 3, 2025, enhances Jabil’s presence in pharmaceutical development and manufacturing. With this
Ardena, a contract development and manufacturing organisation (CDMO) and bioanalytical contract research organisation (CRO), has announced the acquisition of Catalent’s drug product manufacturing facility in Somerset, New Jersey. The move marks a key step in Ardena’s North American expansion, enhancing
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
